Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
epirubicin (ellence) (1 trial)
etoposide (vepesid) (1 trial)
prednisone (meticorten) (1 trial)
Hepatitis B (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Trials (1 total)
Trial APIs (4 total)